Molecular profile of FLT3-mutated relapsed/refractory AML patients in the phase 3 ADMIRAL study of gilteritinib
Article in Blood Advances (March 2022)
The most recent citing publications are shown below. View all 69 publications that cite this research output on Dimensions.
Article in Blood Advances (March 2022)
Article in Life (January 2022)
Article in Asia-Pacific Journal of Clinical Oncology (November 2021)